Halocarbon Poised to Sell Sevoflurane

Specialty fluorochemicals producer Halocarbon (River Edge; NJ) says it is about to begin selling the fluorinated anesthetic sevoflurane in large volumes in the U.S. following FDA approval. Sevoflurane is currently produced by two major pharma companies in a multi-billion dollar market. “If we secured 5% of the market that would be nice,” says Ron Epstein, sales director/Halocarbon, speaking at the recent Chemspec Europe specialty chemicals expo in Münich.   The company says it has yet to decide whether to sell the product directly or...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers